University of Cambridge (cam.ac.uk)

Long hours running COVID-19 vaccine and drugs trials have left little time for Estée Török to contemplate her postponed wedding. With over 20 years' clinical research experience in infectious diseases in the UK and south-east Asia, she has a great deal to contribute to tackling the pandemic.

Eight Cambridge researchers - six from the University of Cambridge and two from the MRC Laboratory of Molecular Biology - are among the 63 scientists from around the world elected this year as Members and Associate Members of the European Molecular Biology Organisation (EMBO).
 

Dr Michaël De Volder, Reader in Nanomanufacturing at the University of Cambridge, has been awarded funding of two million euros from the European Research Council (ERC) to manufacture Li-Ion batteries with enhanced energy and power density for use in electric vehicles.

COVID-19 is comparable to climate and extinction emergencies, say scientists from the UK and US – all share features such as lagged impacts, feedback loops, and complex dynamics.

A team of three PhD students has been awarded business-led innovation funding by Innovate UK.  Jennifer Ward George, Victor Parchment, and Alex Tsompanidis will work together on an inventive software platform known as SOAP to help control the spread of COVID-19 in displaced communities and refugee camps.

Women who experience high blood pressure during pregnancy are more likely to develop heart disease and heart failure in later life, according to an international team of researchers.

Children whose fathers make time to play with them from a very young age may find it easier to control their behaviour and emotions as they grow up, research suggests.

Cambridge-led study discovers new genetic causes of rare diseases, potentially leading to improved diagnosis and better patient care.

Problems in how the brain recognizes and processes novel information lie at the root of psychosis, researchers from the University of Cambridge and King’s College London have found. Their discovery that defective brain signals in patients with psychosis could be altered with medication paves the way for new treatments for the disease.